INTRODUCTION
Immunisation is one of the most effective, safe and cost-effective health interventions. Vaccination policy aims to protect individuals and communities from the risks of infectious diseases. National and local policy aims to achieve high levels of immunisation coverage to create 'herd immunity'. The whole community is protected when 'herd immunity' levels of vaccination coverage are achieved. For most diseases, this is usually around 95% coverage. This level is sufficiently high to prevent any sustained circulation of infections, protecting everyone in the population whether they have been immunised or not.
Immunisation rates in Islington and London have been consistently lower than the national average, and well below 'herd immunity' levels, meaning there is greater risk of outbreaks of preventable diseases such as measles, mumps or rubella.
WHAT ARE THE KEY ISSUES?
The reported uptake of vaccination in parts of England, including Islington and London, has been significantly lower in recent years compared with long-term trends, and significantly below the 'herd immunity' levels necessary to prevent outbreaks.
Some of the reduction in vaccination rates has been associated with public anxiety created by reports possibly linking the MMR vaccination with autism and irritable bowel disease. Although the reports have been comprehensively discredited, there has been lasting impact on MMR vaccination coverage. Rates have improved but have continued to be significantly below the other universal childhood immunisations.
Another, more local, factor relates to population mobility which adds to difficulties in ensuring immunisation status is represented accurately on child health systems so that true levels of coverage can be reported and unimmunised children can be accurately identified and followed up.
Deprivation is also an important factor in Islington. National evidence shows that inequalities in immunisation uptake have been persistent and result in lower  Some ethnic groups -however the relationship between ethnicity, social class, deprivation and level of immunisation uptake is complex.
THE ISLINGTON PICTURE
Childhood immunisation rates have tended to be lower in Islington than the national average and lower than the recommended level of 95% cover necessary to prevent In 2008/09, 2,043 BCG vaccinations were given.
Hepatitis B and rubella
Vaccination coverage rates for neonatal/infant Hepatitis B and postpartum MMR remain below expected levels.
HPV
The 2008/09 academic year was the first year of the human papillomavirus (HPV) vaccination programme. In Islington 66% of girls in Year 8 received all three doses of the vaccine, higher than London, but lower than England at 70%.
FUTURE TRENDS
The national immunisation programme has grown in recent years, with the introduction of new vaccines to prevent a wider range of infectious diseases, and further expansion of the programme over time can be expected. Alongside the introduction of new vaccines, there has also been a growing emphasis on catch-up programmes. These have sought to boost community-level protection among 4 children and young people against diseases where immunisation rates have been significantly below herd immunity levels and so reduce the risk of community outbreaks.
London, particularly inner London, has shown consistently lower levels of immunisation coverage than the rest of the country. The actions put in place locally over the past year described below will need to be sustained in the long term to ensure rates continue to show improvement. Delivery of immunisation therefore will continue to be a significant programme for primary care services and for health visiting and school health services. Services working in institutional settings such as schools have an important role in catch-up programmes and in support of new vaccinations for older children.
SERVICES CURRENTLY PROVIDED IN ISLINGTON
The majority of primary childhood immunisations are carried out by GP practices, 
NATIONAL DRIVERS FOR SERVICE PROVISION
The national immunisation programme covers courses of primary immunisations, together with booster doses to maintain ongoing immunity, for a range of diseases such as Measles Mumps Rubella, Hib meningitis, diphtheria, tetanus, polio, whooping cough and meningitis C. Primary courses of the vaccines are given at specified ages and, for some vaccines, boosters (additional doses) are given to maintain the duration of immunity. As well as the universal national immunisations, neonatal hepatitis B vaccination is given to babies born to mothers who are hepatitis B positive, to reduce the risk of mother-to-child transmission, and neonatal BCG vaccination for TB is given to babies in areas with higher levels of TB.
Islington's immunisation strategy has been based on models of effective practice, 
PROGRESS SINCE LAST YEAR'S JSNA
In recognition of the need to improve the uptake of childhood immunisations, a significant programme of development is underway which has resulted in an initial substantial improvement in immunisation, as described above. Actions to increase uptake of immunisations are set out in Islington's Childhood Immunisation Strategy and Action Plan (2009), which has invested and targeted resources to:
 Establish an immunising team, headed by an immunisation specialist and to include a nurse co-ordinator and administration post.
 Further develop immunisation clinics within Children's Centres, and improve access to the clinics.
 Enhance data quality and accuracy, leading to improved targeting and follow up of unimmunised children.
 Ensure there is a robust governance structure supporting delivery of the strategy.
OPPORTUNITIES FOR DEVELOPMENT
Opportunities for development to improve the uptake of childhood immunisations include:
 Data flow, accuracy and quality. Discrepancies remain between the child health system and GP systems for childhood immunisations. Data quality, flow and recording are being addressed as part of a wider immunisation strategy aimed at increasing uptake of immunisations in Islington. As part of the development, consideration should be given to local flexibility to align the primary care payments system for immunisation with the reporting system.
 Improving access to clinics and immunisations, including for example, clinic times and domiciliary vaccination with families who are harder to engage with.
 Issues specific to the BCG vaccination for older children to improve timeliness of vaccination. This is partly linked to staff turnover, and training to read the Mantoux test results. There is one paediatrician available to supervise practice, however opportunities to become competent in the reading of
RECOMMENDATIONS
 To improve the data flow, collection and analysis of immunised and unimmunised children, bringing together data from primary care, universal children's services and other relevant sources.
 To review the use of patient reminder and recall systems in order to improve immunisation rates.
 To improve the offer and availability of immunisation services, working through primary care, community health and children's settings as indicated.
 To ensure the delivery of immunisation at home (domiciliary visits) for harder to engage families.
 To promote and raise awareness of the facts about immunisation across children's workforce and settings.
 To implement the immunisation strategy and action plan in partnership with all stakeholders including primary care.
FURTHER INFORMATION
Immunisation. A comprehensive and carefully researched information website about immunisation, vaccines and the diseases they protect against.
www.immunisation.nhs.uk/ Guidance on differences in the uptake of immunisations (including targeted vaccines) in people younger than 19 years. NICE guidance PH21 (2009) www.nice.org.uk/PH21 8
